Download PTU B.Sc-BT 2020 March 6th Sem 47070 Drug Designing And Drug Delivery System Question Paper

Download PTU (I.K. Gujral Punjab Technical University Jalandhar (IKGPTU) B.Sc. in Biotechnology 2020 March Previous Question Papers

1 | M - 4 7 0 7 0 ( S 2 ) - 1 9 5 5
Roll No. Total No. of Pages : 02
Total No. of Questions : 09
B.Sc. (BT) (2014 to 2017) (Sem.?6)
DRUG DESIGNING AND DRUG DELIVERY SYSTEM
Subject Code : BSBT-314
M.Code : 47070
Time : 3 Hrs. Max. Marks : 60
INSTRUCTION TO CANDIDATES :
1. SECTION-A is COMPULSORY consisting of TEN questions carrying TWO marks
each.
2. SECTION-B contains FIVE questions carrying FIVE marks each and students
have to attempt ANY FOUR questions.
3. SECTION-C contains THREE questions carrying TEN marks each and students
have to attempt ANY TWO questions.

SECTION-A
1. Define the following :
a. Cellstrain
b. Recombinant Protein
c. Soft Drugs
d. Docking
e. ANDA
f. Post Marketing Trial
g. Matrix Drug Delivery System
h. Microparticles
i. Attenuated Vaccines
j. Orange Book
FirstRanker.com - FirstRanker's Choice
1 | M - 4 7 0 7 0 ( S 2 ) - 1 9 5 5
Roll No. Total No. of Pages : 02
Total No. of Questions : 09
B.Sc. (BT) (2014 to 2017) (Sem.?6)
DRUG DESIGNING AND DRUG DELIVERY SYSTEM
Subject Code : BSBT-314
M.Code : 47070
Time : 3 Hrs. Max. Marks : 60
INSTRUCTION TO CANDIDATES :
1. SECTION-A is COMPULSORY consisting of TEN questions carrying TWO marks
each.
2. SECTION-B contains FIVE questions carrying FIVE marks each and students
have to attempt ANY FOUR questions.
3. SECTION-C contains THREE questions carrying TEN marks each and students
have to attempt ANY TWO questions.

SECTION-A
1. Define the following :
a. Cellstrain
b. Recombinant Protein
c. Soft Drugs
d. Docking
e. ANDA
f. Post Marketing Trial
g. Matrix Drug Delivery System
h. Microparticles
i. Attenuated Vaccines
j. Orange Book
2 | M - 4 7 0 7 0 ( S 2 ) - 1 9 5 5
SECTION-B
2. Discuss the therapeutic potential of subunit vaccines.
3. Discuss different methods of site specific drug delivery.
4. Describe the activities in phase II clinical trials.
5. Discuss the drawbacks of transdermal drug delivery.
6. Discuss the applications of liposomes.

SECTION-C
7. Discuss the structural modification of natural therapeutic compounds.
8. Discuss the steps undertaken by FDA for drug approval.
9. Discuss the preparation and applications of monoclonal antibodies.










NOTE : Disclosure of Identity by writing Mobile No. or Making of passing request on any
page of Answer Sheet will lead to UMC against the Student.
FirstRanker.com - FirstRanker's Choice